Nanosonics is an Australian infection prevention company that has developed and commercialized the trophon®, an automated disinfection technology for ultrasound probes. This breakthrough innovation represents a significant advancement in high level disinfection for ultrasound probes, addressing a crucial need in the healthcare industry. Establishing itself as the global standard of care for ultrasound probe disinfection, Nanosonics continues to enhance its product and services, as well as the overall infrastructure. The company is dedicated to nurturing its employees and providing diverse growth opportunities within the organization. The vision of "Infection Prevention. For Life" unites the Nanosonics team globally, fostering an environment of shared purpose and collaboration. With a strong presence in multiple countries, including the US, UK, Japan, and Canada, Nanosonics is poised for continued expansion and influence in the healthcare, information technology, and manufacturing sectors.
For more information, visit www.nanosonics.com.
There is no investment information
No recent news or press coverage available for Nanosonics.